Marshall Wace Funds LP - MW Eureka (US) Fund II

The five named GPs alongside Marshall Wace Ltd. as the primary GP entity suggests a distributed decision-making structure rather than a single-founder model; this operational setup—where Gregory Bennett, Patrick Flaherty, Barbara Healy, and Marion Mulvey are all named—indicates the fund relies on committee-based investment judgment and raises succession risk if any GP exits, a material consideration for LP continuity.

Filing an amendment in June 2026 during mid-year suggests either a soft launch extension (pushing the close into H2 2026) or a response to slower early-stage commitment velocity; hedge fund capital historically clusters around year-end closes and spring fundraising cycles, so a mid-year amendment typically signals either extended targeting of specific LP cohorts or undersubscription requiring timeline adjustment.

Verify whether Fund I has a key-man clause tied to any single GP and whether that clause survives the move to Fund II; also confirm Marshall Wace's EDGAR filing history directly with the SEC, as 'none found' on a public search may indicate filings under a parent entity, alternative CRD structure, or truly no prior SEC-registered vehicles—a gap that affects due diligence depth on prior fund performance.